Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

New Technology Transfer Agreement Signed

6 Mar 2013 07:00

RNS Number : 3252Z
Surface Transforms PLC
06 March 2013
 



 

Surface Transforms plc

 

("Surface Transforms" or the "Company")

 

New Technology Transfer Agreement Signed with Major Global

Clutch & Transmission Manufacturer

 

Surface Transforms (AIM:SCE) is pleased to announce it has signed a non-exclusive agreement worth US$1.0 million in revenue over the next 12 months with a major global manufacturer of clutch and transmission systems. The agreement relates to the transfer of one of Surface Transforms' in-house developed process technologies, a technology which is only one stage of ST's multi-stage production process for carbon-ceramic brake disc components, and includes the sale of specialist equipment and an option to purchase further process technology and equipment worth approximately US$1.5 million. 

 

A five year licence is included in the agreement, commencing 2018, should they choose to manufacture and sell carbon ceramic components using Surface Transforms' process technology. The global manufacturer will not manufacture or sell carbon ceramic products using the Company's process technology prior to 2018.

 

This global manufacturer is an existing customer of Surface Transforms and the Company will continue to supply processing to them during 2013.

 

However, a short-term adverse development for Surface Transforms is that Genii Capital - the 50% owner of Mov'It - has decided to put their share of Mov'It up for sale and is using the German administration process to minimise costs and facilitate the sale. As previously announced on 3 March 2011, Surface Transforms has a significant distribution agreement with Mov'It. Whilst the Company's assets at Mov'It's are safe, the turmoil will reduce short term sales at Surface Transforms.

 

The Board considers the net effect of both events will be neutral on profits and cash during the current financial year but positive on both during the year ending May 2014; turnover will be lower than market expectations for the current financial year but in line with expectations for the year ending May 2014.

 

David Bundred, Chairman of Surface Transforms said:

 

"The Company welcomes the partnership with this global manufacturer of clutch and transmission systems and is looking forward to continuing to work with them. This development confirms the strategy that the Company is amenable to achieving shareholder value through licensing as well as direct sales. The fact that this good news on licensing is partially offset by sales developments at Mov'It is disappointing. However the Company is working with Mov'It to ensure that their temporary problems will soon be resolved."

 

- Ends -

 

Enquiries:

 

Surface Transforms Plc

 

Dr. Kevin Johnson, CEO

+44 151 356 2141

David Bundred, Chairman

+44 7785 388 848

 

 

Cantor Fitzgerald Europe

+44 207 107 8000

David Foreman / Guy Peters (Corporate Finance)

 

Paul Jewell (Corporate Broking)

 

 

 

 

Notes to Editors:

 

www.surface-transform.com

 

Surface Transforms plc is the UK's leading manufacturer of `next-generation' carbon fibre reinforced ceramic composite materials (CRFCs).It is one of two global manufacturers of carbon ceramic brake discs and the Company's high-performance products are being commercialised with major industry partners, for an expanding range of innovative global applications in automobile brakes, aircraft brakes and rocket components.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRUGUCGWUPWPWA
Date   Source Headline
1st May 20207:00 amRNSResult of over-subscribed open offer
24th Apr 20204:17 pmRNSHolding(s) in Company
23rd Apr 202011:35 amEQSHardman & Co Research: Q&A with Mike Foster on Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
21st Apr 20207:00 amRNSOpen Offer application form - update
20th Apr 202010:20 amRNSHolding(s) in Company
17th Apr 20203:15 pmEQSHardman & Co Research: Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
9th Apr 20203:00 pmRNSPlacing and Open Offer
27th Mar 20207:00 amRNSDeferral of Publication of Results &COVID19 Update
28th Feb 20207:00 amRNSUnaudited interims for the 6 m/e 30 November 2019
10th Feb 20208:27 amRNSHolding(s) in Company
28th Jan 20205:30 pmRNSAppointment of Sales Director and Grant of Options
27th Jan 20202:00 pmRNSDirector/PDMR Shareholding
10th Jan 20207:00 amRNSTrading and operational update
5th Dec 20197:00 amRNSGrant of options
13th Nov 20198:33 amRNSExercise of options
13th Nov 20198:27 amRNSResult of AGM
6th Nov 201910:01 amRNSHolding(s) in Company
6th Nov 20199:00 amRNSExercise of Options and PDMR Dealing
25th Oct 201912:56 pmEQSHardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects
17th Oct 20197:00 amRNSPosting of Annual Report and Notice of AGM
2nd Oct 201910:55 amRNSDirector/PDMR Shareholding
26th Sep 20197:00 amRNSContract award from OEM 1
19th Sep 20197:00 amRNSCapital Markets Day
18th Sep 201910:50 amRNSHolding(s) in Company
9th Sep 20197:00 amRNSPreliminary results and notice of AGM
5th Sep 20194:10 pmEQSHardman & Co Research: Surface Transforms (SCE): Rapid acceleration - 'game-change' announcements
27th Aug 20197:00 amRNSContract Agreement with German OEM 5
15th Aug 20197:00 amRNSChange of Financial Year End Date
16th Jul 20197:00 amRNSContract award from German OEM 5
28th Jun 20197:00 amRNSContract Awards and Commercial Settlement
16th May 20197:00 amRNSDirector/PDMR Shareholding
7th May 20199:05 amRNSSecond Price Monitoring Extn
7th May 20199:00 amRNSPrice Monitoring Extension
7th May 20197:00 amRNSTrading Update
28th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20195:05 pmRNSHolding(s) in Company
20th Mar 20197:00 amRNS£1.9 million placing
26th Feb 20197:00 amRNSInterim Results
11th Dec 20185:36 pmRNSResult of AGM
6th Dec 20187:00 amRNSExercise of Options and Director Dealing
5th Dec 20187:00 amRNSGrant of Options
4th Dec 20187:00 amRNSTrading & Operational Update
17th Sep 20187:00 amRNSPreliminary Results and Notice of AGM
10th Sep 20187:00 amRNSBoard appointment
4th Jul 20183:19 pmRNSGrant of options
3rd Jul 20187:00 amRNSHolding(s) in Company
27th Jun 20188:38 amRNS£1.5 Million Placing
13th Jun 20187:00 amRNSPre Close Trading, Customer and Operations Update
10th May 20187:00 amRNSDirector/PDMR Shareholding
12th Apr 20187:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.